Reuters logo
BRIEF-Vistin Pharma Q2 EBITDA down at NOK 12.4 mln
August 31, 2017 / 5:17 AM / 3 months ago

BRIEF-Vistin Pharma Q2 EBITDA down at NOK 12.4 mln

Aug 31 (Reuters) - VISTIN PHARMA ASA :

* Q2 TOTAL REVENUE AND INCOME NOK 54.1 MILLION VERSUS NOK 54.6 MILLION YEAR AGO

* Q2 EBITDA NOK 12.4 MILLION VERSUS NOK 13.3 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below